A Randomized Phase II Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in HER2 Amplified Irinotecan-Refractory Metastatic Colorectal Cancer (mCRC)

SWOG-S1613
Cancer - Colon, Cancer - Rectum
Farshid Dayyani
Open
Treatment
Campto, Cetuximab, Erbitux, Herceptin, Irinotecan, Pertuzumab, Trastuzumab
II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.